Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
David Haas, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT00729924
First received: August 4, 2008
Last updated: February 12, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
No publications provided by Vanderbilt University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):